Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
Published April 29, 2026 · Recall initiated: March 20, 2026
Summary
FDA records drug Class II recall D-0486-2026, published April 29, 2026 and initiated March 20, 2026. Recalling firm: Leading Pharma, LLC; Status: Ongoing; Reported quantity: 9384 bottles; Lot: Lots# H03125, H03225, H03325, Exp Date: 2027/08. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
What to do
Voluntary: Firm initiated · Letter
Get an email if FUROSEMIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FUROSEMIDE
- Manufacturer
- Leading Pharma, LLC
- Distributor
- US Nationwide.
- Lot
- Lots# H03125, H03225, H03325, Exp Date: 2027/08
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: CamberApril 29, 2026
- FDAFRESHKOTE LUBRICANT EYEDROPS, Sterile, 0.33 FL OZ (10mL), Harrow Eye LLC, Nashville, TN USA.April 29, 2026
- FDAFurosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., EastJanuary 28, 2026
- FDAFurosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216,February 1, 2017
- FDAFurosemide Injection, USP, 40 mg/4mL (10 mg/mL), 4 ml Single-Dose Vial, Rx only, HOSPIRA, INC. LAKE FOREST, ILMay 15, 2013
- FDAFurosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDCMarch 6, 2013
Questions about this recall
Was Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01 recalled?
Yes. FDA published recall D-0486-2026 on April 29, 2026. Reported hazard: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FUROSEMIDE.